Postoperative Analgesic Effect of Esketamine

Sponsor
Xuanhan County People's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05582135
Collaborator
(none)
119
1
4
3.4
35.2

Study Details

Study Description

Brief Summary

The aim of this study was to determine whether the addition of esketamine to morphine would improve postoperative analgesia after caesarean section.

Parturients who planned for a caesarean delivery using combined spinal-epidural anaesthesia with a request for postoperative anaesthesia were randomly divided into four groups (A, B, C and D). When the surgery was completed, the parturients in groups A, B, C and D were administered 2 mg morphine, 0.25mg/kg of esketamine, 0.25mg/kg of esketamine plus 2 mg morphine sulfate and 0.25mg/kg of esketamine plus 1 mg morphine through the epidural catheters, respectively. The postoperative pain at rest, pain with movement, the number of rescue analgesics and adverse effects were evaluated for 48 h after caesarean delivery.

Condition or Disease Intervention/Treatment Phase
  • Drug: 2 mg morphine sulfate
  • Drug: 0.25mg/kg esketamine
  • Drug: 0.25mg/kg of esketamine in combination with 2 mg morphine sulfate
  • Drug: 0.25mg/kg of esketamine in combination with 1 mg morphine sulfate
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
119 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Epidural Esketamine and Morphine for Postoperative Analgesia After Caesarean Delivery: A Pilot Study
Actual Study Start Date :
May 5, 2021
Actual Primary Completion Date :
Aug 16, 2021
Actual Study Completion Date :
Aug 16, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: group A

The parturients in group A were administered 2 mg morphine sulfate through the epidural catheter.

Drug: 2 mg morphine sulfate
The parturients were administered 2 mg morphine sulfate through the epidural catheter. Sterile saline was added to make a total volume of 8 mL.

Active Comparator: group B

The parturients in group B were administered 0.25mg/kg of esketamine.

Drug: 0.25mg/kg esketamine
The parturients were administered 0.25mg/kg of esketamine through the epidural catheter. Sterile saline was added to make a total volume of 8 mL.

Active Comparator: group C

The parturients in group C were administered 0.25mg/kg of esketamine in combination with 2 mg morphine sulfate.

Drug: 0.25mg/kg of esketamine in combination with 2 mg morphine sulfate
The parturients were administered 0.25mg/kg of esketamine in combination with 2 mg morphine sulfate through the epidural catheter. Sterile saline was added to all combinations of the analgesic drugs to make a total volume of 8 mL.

Active Comparator: group D

The parturients in group D were administered 0.25mg/kg of esketamine in combination with 1 mg morphine sulfate.

Drug: 0.25mg/kg of esketamine in combination with 1 mg morphine sulfate
The parturients were administered 0.25mg/kg of esketamine in combination with 1 mg morphine sulfate through the epidural catheter. Sterile saline was added to all combinations of the analgesic drugs to make a total volume of 8 mL.

Outcome Measures

Primary Outcome Measures

  1. Postoperative pain score at rest [Two hours after caesarean delivery]

    The pain scores at rest were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  2. Postoperative pain score at rest [Four hours after caesarean delivery]

    The pain scores at rest were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  3. Postoperative pain score at rest [Eight hours after caesarean delivery]

    The pain scores at rest were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  4. Postoperative pain score at rest [Twelve hours after caesarean delivery]

    The pain scores at rest were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  5. Postoperative pain score at rest [Twenty-four hours after caesarean delivery]

    The pain scores at rest were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  6. Postoperative pain score at rest [Forty-eight hours after caesarean delivery]

    The pain scores at rest were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  7. Postoperative pain score with movement [Two hours after caesarean delivery]

    The pain scores on movement were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  8. Postoperative pain score with movement [Four hours after caesarean delivery]

    The pain scores on movement were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  9. Postoperative pain score with movement [Eight hours after caesarean delivery]

    The pain scores on movement were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  10. Postoperative pain score with movement [Twelve hours after caesarean delivery]

    The pain scores on movement were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  11. Postoperative pain score with movement [Twenty-four hours after caesarean delivery]

    The pain scores on movement were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  12. Postoperative pain score with movement [Forty-eight hours after caesarean delivery]

    The pain scores on movement were evaluated by the parturients themselves using a VAS based on a linear scale from 0 to 10, where 0 represented an absence of pain and 10 represented maximal pain.

  13. number of rescue analgesics required [within Forty-eight hours of surgery]

    The number of rescue analgesics required within 48 h of surgery was recorded

Secondary Outcome Measures

  1. systolic blood pressure (SBP) [Two hours after caesarean delivery]

    Patient's systolic blood pressure (SBP)

  2. systolic blood pressure (SBP) [Four hours after caesarean delivery]

    Patient's systolic blood pressure (SBP)

  3. systolic blood pressure (SBP) [Eight hours after caesarean delivery]

    Patient's systolic blood pressure (SBP)

  4. systolic blood pressure (SBP) [Twelve hours after caesarean delivery]

    Patient's systolic blood pressure (SBP)

  5. systolic blood pressure (SBP) [Twenty-four hours after caesarean delivery]

    Patient's systolic blood pressure (SBP)

  6. systolic blood pressure (SBP) [Forty-eight hours after caesarean delivery]

    Patient's systolic blood pressure (SBP)

  7. diastolic blood pressure (DBP) [Two hours after caesarean delivery]

    Patient's diastolic blood pressure (DBP)

  8. diastolic blood pressure (DBP) [Four hours after caesarean delivery]

    Patient's diastolic blood pressure (DBP)

  9. diastolic blood pressure (DBP) [Eight hours after caesarean delivery]

    Patient's diastolic blood pressure (DBP)

  10. diastolic blood pressure (DBP) [Twelve hours after caesarean delivery]

    Patient's diastolic blood pressure (DBP)

  11. diastolic blood pressure (DBP) [Twenty-four hours after caesarean delivery]

    Patient's diastolic blood pressure (DBP)

  12. diastolic blood pressure (DBP) [Forty-eight hours after caesarean delivery]

    Patient's diastolic blood pressure (DBP)

  13. heart rate (HR) [Two hours after caesarean delivery]

    Patient's heart rate (HR)

  14. heart rate (HR) [Four hours after caesarean delivery]

    Patient's heart rate (HR)

  15. heart rate (HR) [Eight hours after caesarean delivery]

    Patient's heart rate (HR)

  16. heart rate (HR) [Twelve hours after caesarean delivery]

    Patient's heart rate (HR)

  17. heart rate (HR) [Twenty-four hours after caesarean delivery]

    Patient's heart rate (HR)

  18. heart rate (HR) [Forty-eight hours after caesarean delivery]

    Patient's heart rate (HR)

  19. Blood oxygen saturation (SpO2) [Two hours after caesarean delivery]

    Measurement of pulse Blood oxygen saturation (SpO2) in parturients

  20. Blood oxygen saturation (SpO2) [Four hours after caesarean delivery]

    Measurement of pulse Blood oxygen saturation (SpO2) in parturients

  21. Blood oxygen saturation (SpO2) [Eight hours after caesarean delivery]

    Measurement of pulse Blood oxygen saturation (SpO2) in parturients

  22. Blood oxygen saturation (SpO2) [Twelve hours after caesarean delivery]

    Measurement of pulse Blood oxygen saturation (SpO2) in parturients

  23. Blood oxygen saturation (SpO2) [Twenty-four hours after caesarean delivery]

    Measurement of pulse Blood oxygen saturation (SpO2) in parturients

  24. Blood oxygen saturation (SpO2) [Forty-eight hours after caesarean delivery]

    Measurement of pulse Blood oxygen saturation (SpO2) in parturients

  25. Adverse events [within Forty-eight hours of surgery]

    Adverse events that occurred after the administration of study drugs were also recorded.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 32 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • nulliparous parturients who scheduled for elective caesarean delivery under spinal-epidural anaesthesia;

  • parturients who had requested postoperative analgesia;

  • parturients aged between 20-35 years old;

  • parturients who had a full-term pregnancy;

  • parturients who were identified as having a singleton pregnancy; and

  • parturients who were categorised as having an American Society of Anaesthesiologists (ASA) physical status

Exclusion Criteria:
  • parturients with severe internal, surgical or obstetric comorbidities (including spinal deformities, hypertension, placental abruption, cholestasis in pregnancy, asthma, heart disease and abnormal coagulation parameters)

  • parturients with a known allergy to the drugs used in this study

  • parturients with severe mental illness who could not comply with doctors' instructions

  • parturients with chronic pain syndrome, which is defined as pain that persists for a period longer than 3 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Qijun Ran Dazhou Sichuan China 636150

Sponsors and Collaborators

  • Xuanhan County People's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xuanhan County People's Hospital
ClinicalTrials.gov Identifier:
NCT05582135
Other Study ID Numbers:
  • XuanhanCo
First Posted:
Oct 17, 2022
Last Update Posted:
Oct 17, 2022
Last Verified:
Oct 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 17, 2022